OCSOculis Holding AG Ordinary shares

CSNasdaq (XNAS)·USD

Identity

Security key: 19543
Ticker: OCS
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2023-03-03
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: OCS

Detail

Enriched 2026-08-14 20:47

Market cap: $715,755,417.29
Shares outstanding (class): 57,984,438
Shares outstanding (weighted): 55,527,961
SIC: —
Employees: 60
Location: —
Homepage: https://www.oculis.com
Description: Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Market cap and share counts drift.

Funds holding this security

13 funds · 17 positions · $64.09M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
abrdn Healthcare Investors —	—	$15.41M	1.36%	579,536 NS	TICKER
abrdn Healthcare Opportunities Fund —	—	$15.15M	2.10%	569,796 NS	TICKER
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST	—	$11.43M	0.72%	430,000 NS	TICKER
abrdn World Healthcare Fund —	—	$9.14M	1.90%	343,874 NS	TICKER
abrdn Life Sciences Investors —	—	$6.75M	1.20%	253,740 NS	TICKER
Simplify Propel Opportunities ETF Simplify Exchange Traded Funds	SURI	$1.77M	2.56%	66,667 NS	TICKER
HARTFORD SMALL COMPANY HLS FUND HARTFORD SERIES FUND INC	—	$1.21M	0.31%	45,414 NS	TICKER
Small Cap Stock Trust John Hancock Variable Insurance Trust	—	$764.2K	0.31%	28,741 NS	TICKER
State Street(R) SPDR(R) S&P(R) International Sm… SPDR INDEX SHARES FUNDS	GWX	$505.2K	0.06%	19,000 NS	TICKER
MassMutual Small Cap Growth Equity Fund MASSMUTUAL SELECT FUNDS	—	$493.5K	0.09%	18,560 NS	TICKER
HARTFORD HEALTHCARE HLS FUND HARTFORD SERIES FUND INC	—	$463.8K	0.44%	17,442 NS	TICKER
State Street(R) SPDR(R) US Small Cap Low Volati… SPDR SERIES TRUST	SMLV	$427.8K	0.16%	16,088 NS	TICKER
MML Small Cap Growth Equity Fund MML SERIES INVESTMENT FUND	—	$206.6K	0.15%	7,770 NS	TICKER
GlacierShares Nasdaq Iceland ETF Listed Funds Trust	GLCR	$170.9K	11.39%	6,426 NS	TICKER
Small Cap Core Fund Northern Funds	—	$167.4K	0.05%	6,295 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKEROCS
CIK0001953530
ISINCH1242303498
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: Oculis is a biopharmaceutical company developing treatments for eye diseases, fitting healthcare biotechnology.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.